Home›Screener›NVO›Profile

F

9/100

Novo Nordisk

NVODiabetes/Obesity

← Signals View

📋

Analyst Summary

✓ VERIFIED2026-04-11

Novo Nordisk (NVO) is the lead sponsor of 91 active clinical trials listed on ClinicalTrials.gov^[5], including 32 Phase 3^[1], 9 Phase 2^[2], 17 Phase 1^[3], 3 Phase 4^[4].

Trial NCT05330325^[6] evaluates Somapacitan in SGA, Turner Syndrome, Noonan Syndrome, ISS with a target enrollment of 412 participants. Trial NCT05567796^[7] evaluates Cagrilintide in Obesity with a target enrollment of 3400 participants. Trial NCT03811561^[8] evaluates Semaglutide in Diabetes Mellitus, Type 2 with a target enrollment of 1500 participants.

Sources

ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov · NCT05330325 (2026-03-13) ↗
ClinicalTrials.gov · NCT05567796 (2026-03-30) ↗
ClinicalTrials.gov · NCT03811561 (2026-03-11) ↗

🔬

Clinical Trials

91

NCT01511393Diabetes, Diabetes Mellitus, Type 2, Medullary Thyroid Carcinoma, Weight Management

clinicaltrials_gov · Retrieved 2026-04-11

NCT03690336Haemophilia B

clinicaltrials_gov · Retrieved 2026-04-11

NCT03745924Haemophilia B

clinicaltrials_gov · Retrieved 2026-04-11

NCT03811561Diabetes Mellitus, Type 2

clinicaltrials_gov · Retrieved 2026-04-11

NCT03878446Short Stature Children Born Small for Gestational Age (SGA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT03972345Growth Hormone Deficiency in Children, Born Small for Gestational Age

clinicaltrials_gov · Retrieved 2026-04-11

NCT04042402Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases, Urologic Diseases, Genetic Disease, Primary Hyperoxaluria Type 3 (PH3)

clinicaltrials_gov · Retrieved 2026-04-11

NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors

clinicaltrials_gov · Retrieved 2026-04-11

NCT04083781Haemophilia A With Inhibitors, Haemophilia B With Inhibitors

clinicaltrials_gov · Retrieved 2026-04-11

NCT04574076Haemophilia A

clinicaltrials_gov · Retrieved 2026-04-11

NCT04580420Primary Hyperoxaluria Type 1, End Stage Renal Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT04682145Haemophilia A

clinicaltrials_gov · Retrieved 2026-04-11

NCT04775082Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT04822181Non-alcoholic Steatohepatitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05021835Cardiovascular Risk, Chronic Kidney Disease, Inflammation

clinicaltrials_gov · Retrieved 2026-04-11

NCT05135559Haemophilia A and B With and Without Inhibitors

clinicaltrials_gov · Retrieved 2026-04-11

NCT05230550Adult Growth Hormone Deficiency

clinicaltrials_gov · Retrieved 2026-04-11

NCT05308927Noonan Syndrome

clinicaltrials_gov · Retrieved 2026-04-11

NCT05330325SGA, Turner Syndrome, Noonan Syndrome, ISS

clinicaltrials_gov · Retrieved 2026-04-11

NCT05503927Pregnancy, Obesity, Overweight

clinicaltrials_gov · Retrieved 2026-04-11

NCT05567796Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT05621746Haemophilia A

clinicaltrials_gov · Retrieved 2026-04-11

NCT05636176Heart Failure

clinicaltrials_gov · Retrieved 2026-04-11

NCT05669755Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT05685238Haemophilia A, Haemophilia A With Inhibitors

clinicaltrials_gov · Retrieved 2026-04-11

NCT05718570Adult Growth Hormone Deficiency

clinicaltrials_gov · Retrieved 2026-04-11

NCT05723835SGA, Turner Syndrome, Noonan Syndrome, ISS

clinicaltrials_gov · Retrieved 2026-04-11

NCT05726227Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT05779475Parkinson Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT05872022Pregnancy, Obesity, Overweight

clinicaltrials_gov · Retrieved 2026-04-11

NCT06109935Growth Hormone Deficiency in Children

clinicaltrials_gov · Retrieved 2026-04-11

NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06200207Heart Failure, Systemic Inflammation

clinicaltrials_gov · Retrieved 2026-04-11

NCT06221969Type 2 Diabetes

clinicaltrials_gov · Retrieved 2026-04-11

NCT06260709Transthyretin Amyloid Cardiomyopathy (ATTR CM)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06269120Type 2 Diabetes

clinicaltrials_gov · Retrieved 2026-04-11

NCT06283667Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06285071Haemophilia A, Haemophilia B

clinicaltrials_gov · Retrieved 2026-04-11

NCT06388187Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06504368Solid Tumors, Adult

clinicaltrials_gov · Retrieved 2026-04-11

NCT06534411Diabetes Mellitus, Type 2

clinicaltrials_gov · Retrieved 2026-04-11

NCT06571383Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06574984Congenital Bleeding Disorder, Haemophilia A

clinicaltrials_gov · Retrieved 2026-04-11

NCT06577766Obesity, Overweight

clinicaltrials_gov · Retrieved 2026-04-11

NCT06609226Sickle Cell Disease, Thalassemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06612268Sickle Cell Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06709040Growth Hormone Deficiency, Neoplasms, Diabetes Mellitus Type 2

clinicaltrials_gov · Retrieved 2026-04-11

NCT06717698Chronic Kidney Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06719011Obesity, Overweight

clinicaltrials_gov · Retrieved 2026-04-11

NCT06780449Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06797869Diabetes Mellitus, Type 2, Diabetic Peripheral Neuropathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT06805539Overweight, Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06807190Diabetes Mellitus, Type 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT06831734Haemophilia A, Haemophilia B

clinicaltrials_gov · Retrieved 2026-04-11

NCT06855563Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06859073Healthy Volunteers, Hyperuricemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06891365Healthy Volunteers, Hepatic Steatosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06979362Heart Failure

clinicaltrials_gov · Retrieved 2026-04-11

NCT06979375Heart Failure

clinicaltrials_gov · Retrieved 2026-04-11

NCT07010432Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07011667Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07018544Obesity and Overweight

clinicaltrials_gov · Retrieved 2026-04-11

NCT07055607Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07076199Diabetes Mellitus, Type 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT07081178Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07087795Diabetes Mellitus, Type 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT07112339Diabetes Mellitus, Type 2

clinicaltrials_gov · Retrieved 2026-04-11

NCT07153172Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07154238Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07157423Severe Postpartum Haemorrhage

clinicaltrials_gov · Retrieved 2026-04-11

NCT07160816Diabetes Mellitus, Type 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT07163260Haemophilia

clinicaltrials_gov · Retrieved 2026-04-11

NCT07184086Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07184632Overweight, Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07207811Transthyretin Amyloid Cardiomyopathy (ATTR CM)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07214870Fatty Liver Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT07218627Heart Failure

clinicaltrials_gov · Retrieved 2026-04-11

NCT07220564Haemophilia A

clinicaltrials_gov · Retrieved 2026-04-11

NCT07220642Obesity, Overweight

clinicaltrials_gov · Retrieved 2026-04-11

NCT07220759Overweight, Obesity, Type 2 Diabetes

clinicaltrials_gov · Retrieved 2026-04-11

NCT07225816Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07238816Haemophilia A

clinicaltrials_gov · Retrieved 2026-04-11

NCT07253285Overweight, Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07270731Healthy Volunteer, Type 2 Diabetes

clinicaltrials_gov · Retrieved 2026-04-11

NCT07271251Type 2 Diabetes

clinicaltrials_gov · Retrieved 2026-04-11

NCT07280221Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07301034Myocardial Infarction

clinicaltrials_gov · Retrieved 2026-04-11

NCT07305805Diabetes Mellitus, Type 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT07339423Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07395687Overweight, Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07437079Overweight, Obesity

clinicaltrials_gov · Retrieved 2026-04-11

👤

Insider Activity

1

0 filings

sec_edgar · Retrieved 2026-04-10

Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.

Score Breakdown

Score Trend

2026-04-132026-06-02

Signal Summary

PDUFA Dates0

Insider Filings1

Clinical Trials1

Data Provenance

cik1 verified

clinical trial91 verified

insider buy1 verified

trial count5 verified

Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR